Samuel Sherman

Samuel Sherman's work spans multiple areas, focusing mainly on anticompetitive behavior, market power, and market definition in pharmaceutical markets, bankruptcy liability valuation, personal injury valuation, and multinational corporation transfer pricing.

He has supported experts through all phases of litigation, bankruptcy, and tax proceedings on a variety of subjects such as False Claims Act, health insurance, medical billing, pharmaceutical marketing, long-term asbestos and talc liabilities, and transfer price audit appeals.

Sam has extensive experience leveraging discovery and legal research tools and translating those efforts into quantitative analysis, as evidenced by his experience in contract analysis, document review, assessment of bankruptcy/medical claim review, and claims data organization.